Collplant Biotechnologies Ltd (CLGN) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, November 15, 2022

Collplant Holdings Ltd.

CIK: 1631487 Ticker: CLGN

View differences made from one to another to evaluate Collplant Holdings Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Collplant Holdings Ltd..


Assess how Collplant Holdings Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Collplant Holdings Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Collplant Holdings Ltd. provided additional information to their SEC Filing as exhibits

Ticker: CLGN
CIK: 1631487
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001213900-22-072561
Submitted to the SEC: Tue Nov 15 2022 7:08:09 AM EST
Accepted by the SEC: Tue Nov 15 2022
Period: Tuesday, November 15, 2022
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: